Skip to main content
. Author manuscript; available in PMC: 2016 Jan 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2015 Jan 1;68(1):55–61. doi: 10.1097/QAI.0000000000000367

Figure 1.

Figure 1

Scatterplot of VL measurements within the first two years of HIV infection, with a Loess smoothing line and 95% confidence intervals, stratified by CAPRISA 004 tenofovir gel and placebo arms